IDO1 and neoplasm: MDSCs are the largest producer of indoleamine 2,3-dioxygenase (IDO), directly acting on the immunosuppressive pathway of anti-tumor CD8+ T lymphocytes and the increase of Treg cell activity in the lung tumor microenvironment (75) (Figure 1).